ALPN - Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.09 revenue of $9.4M beats by $2.52M
2023-05-11 17:24:26 ET
- Alpine Immune Sciences press release ( NASDAQ: ALPN ): Q1 GAAP EPS of -$0.28 beats by $0.09 .
- Revenue of $9.4M (-31.0% Y/Y) beats by $2.52M .
-
As of March 31, 2023, Alpine’s cash and investments totaled $248.3 million, which the Company anticipates is sufficient to fund its planned operations through 2025. The Company recorded net losses of $13.3 million and $7.5 million for the quarters ended March 31, 2023 and 2022, respectively.
For further details see:
Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.09, revenue of $9.4M beats by $2.52M